AAD 2026Abstract 72814
Long-term (≥3 year) efficacy and safety of subcutaneous spesolimab for treatment of generalized pustular psoriasis
results from the EFFISAYIL program
Gudjonsson JE, Navarini AA, Langley RG, Krueger JG, Mostaghimi A, Burden AD, Tang M, Reardon J, Thoma C, Morita A
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Psoriasis
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1154 · Not in PubMed: details from Crossref